Local/therapy
The effect of race on survival after local therapy in metastatic prostate cancer patients
... diagnosed mPCa. CSM was defined according to the SEER mortality code. All other deaths were considered as other-cause mortality (OCM). LT types available in SEER database consist of: 1) radical prostatectomy (RP) ...
12
Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy
... treatment; local application is preferred to systemic drugs when treating only vaginal ...As local estrogen therapies have comparable efficacy, this study aimed to understand treatment practices, assess ...
8
Barriers to effective treatment of vaginal atrophy with local estrogen therapy
... of local estrogen therapy to prime the vaginal epithelium and produce noticeable results (eg, relief of vaginal dryness, irritation, itching, and pain on ...that local estrogen therapy should ...
6
Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy
... with local (or “topical”) vaginal estrogen ...database. Local estrogen therapy is effective and safe for treatment of vaginal atrophy; however, barriers to treatment (eg, patient reluctance to ...
7
Predicting a local recurrence after breast conserving therapy by gene expression profiling
... chemo- therapy treatment [36,37], and prognosis after treatment with tamoxifen ...a local recurrence, this treatment has become standard for more than 60% of breast cancer ...that local recur- rence ...
11
Local thrombolytic therapy in acute mesenteric ischemia
... Acute mesenteric ischemia (AMI) is a lethal disease with high mortality rates ranging from 24 to 94%. This is attrib- uted to delayed diagnosis, ineffective treatment regimens and moribund patients [1-3]. Recent advances ...
5
Surfactant Therapy in Respiratory Distress Syndrome The First Local Experience
... Surfactant Therapy In Respiratory Distress Syndrome The First Local Experience ORIGINAL ARTICLE Surfactant Therapy In Respiratory Distress Syndrome The First Local Experience N L Lim, MRCP M M Nordin,[.] ...
8
The effect of race on survival after local therapy in metastatic prostate cancer patients
... and AA men aged 18 years or older, diagnosed between 2004 and 2014 with histologically confirmed adenocarcin- oma of the prostate (International Classification of Disease for Oncology [ICD-O-3] code 8140 site code ...
7
<p>Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports</p>
... systemic therapy com- bined with local treatment might extend the survival bene fi t in NSCLC patients with oligoprogressive ...of local treatment alone or chemotherapy plus local ablative ...
5
AKhouryPHLP122013_Redacted.pdf
... in local and systemic treatment approaches occurred during this broad span of ...either local therapy within the setting of the current treatment ...radiation therapy after M are more likely ...
61
The local immune landscape determines tumor PD L1 heterogeneity and sensitivity to therapy
... immune-checkpoint blockade in combination with strategies tar- geting the “context” of macrophages and NF-κB signaling. In this study, depleting macrophages does directly impair NF-κB signal- ing–mediated cancer growth. ...
15
To evaluate efficacy of local amikacin therapy as an adjuvant to parentral antibiotics in control of surgical site infection compared to parentral antibiotic alone in a tertiary care centre
... as local antibiotic agent in treating Urinary tract infection as been shown in a Japanese study (76) , in which amikacin was used as bladder wash agent or renal pelvic lavage and vesical ...
106
<p>Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use</p>
... pharmaceutical therapy for VVA (including vaginal oestro- gen or oral SERMS), 18% were “ former users ” of that therapy, 25% were current or former users of over-the- counter (OTC) products like vaginal ...
8
MEDICATED DEVICE COMBINATION PRODUCT: AN OVERVIEW
... In the current scenario more and more development in science and technology had led to the new technology or innovation in the healthcare system, so these advances had led to the existence of Medicated Device Combination ...
7
Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study
... and local physical treatment (iontophoresis, extracorporeal shock wave therapy [ESWT], Capacitive Resistive Energy Trans- fer/TECAR therapy, traction, and vacuum ...
10
A Rare Case of Spinal Osteosarcoma with Extraosseous Component: Review of Literature for Role and Outcome of Radiation Therapy
... the local site, which is insidious in onset and intolerable and can occur during sleep as ...and local warmth in the absence of any evidence of infection and injury, along with weight loss, malaise and ...
5
Surgical minimally invasive treatment of spine metastases
... adjusted therapy of the spine metastases has to be planned (Bartels et ...right therapy has to always be determined on a case by case basis, depending on certain criteria and parameters (clinical, ...
12
Clinical Case: Treatment of a Giant Cells Tumor of the Proximal Femur in a Disadvantaged Area
... [17] Arbeitsgemeinschaft, K., Becker, W.T., Dohle, J., Bernd, L., Braun, A., Cserhati, M., et al . (2008) Local Recurrence of Giant Cell Tumor of Bone after Intralesional Treatment with and without Adjuvant ...
7
Estimate the effectiveness of PRP therapy in intraarticular steroid failed cases of moderate osteoarthritis: in case of advanced aged patients
... PRP therapy that reduces pain and leads to a more effective and lasting functional recovery with local anesthetic in intra-articular steroid failure elderly ...
5
A case of myocardial infarction caused by obstruction of a drug-eluting stent during the perioperative period
... at local hospital chosen DES regardless of scheduled total larygectomy, the discontinuation of antiplatelet therapy, and the surgical staffs failed to share the elevated serum CK and CK-MB values, caused ...
5